Literature DB >> 7705671

Predicting endometrial cancer among older women who present with abnormal vaginal bleeding.

S Feldman1, E F Cook, B L Harlow, R S Berkowitz.   

Abstract

We studied 203 women ages 49 or over who presented with abnormal vaginal bleeding and who underwent either endometrial biopsy or dilation and curettage at the Brigham and Women's Hospital. Using information from the clinical history, we predicted their risk for endometrial cancer (36 patients) or complex endometrial hyperplasia (16 patients). Factors independently associated with endometrial cancer/complex hyperplasia included age 70 or older (OR = 9.1, P = 0.0001), diabetes (OR = 3.7, P = 0.02), and nulliparity (OR = 2.7, P = 0.02). After adjusting for age, menopause was borderline significant (OR = 2.6, P = 0.07). Our data estimated a risk of endometrial cancer/complex hyperplasia of 87% for a woman possessing all of these factors, and a risk of less than 3% if she had none of them. Our model provides an inexpensive, simple means for assessing the risk of endometrial cancer and complex hyperplasia in the post- or perimenopausal woman with abnormal bleeding.

Entities:  

Mesh:

Year:  1995        PMID: 7705671     DOI: 10.1006/gyno.1995.1066

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

2.  Endometrial Cancer Associated Symptoms: A Case-Control Study.

Authors:  Janelle B Pakish; Karen H Lu; Charlotte C Sun; Jennifer K Burzawa; Anthony Greisinger; Frances A Smith; Bryan Fellman; Diana L Urbauer; Pamela T Soliman
Journal:  J Womens Health (Larchmt)       Date:  2016-06-02       Impact factor: 2.681

3.  Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013-12-30

4.  Serum proteomic profile analysis for endometrial carcinoma detection with MALDI-TOF MS.

Authors:  Feng Qiu; Yan H Gao; Chao G Jiang; Ya P Tian; Xue J Zhang
Journal:  Arch Med Sci       Date:  2010-04-30       Impact factor: 3.318

5.  Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.

Authors:  J V Lacey; O B Ioffe; B M Ronnett; B B Rush; D A Richesson; N Chatterjee; B Langholz; A G Glass; M E Sherman
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.